Ohshima, A <br/><br/>
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.  [electronic resource] 

 -  American journal of hematology  Dec 1996 
 - 264-6 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0361-8609 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1096-8652(199612)53:4<264::AID-AJH12>3.0.CO;2-C  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Chromosomes, Human, Pair 11--drug effects<br/>DNA Topoisomerases, Type II--physiology<br/>Enzyme Inhibitors--pharmacology<br/>Etoposide--administration & dosage<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Karyotyping<br/>Leukemia, Monocytic, Acute--drug therapy<br/>Mitoxantrone--administration & dosage<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Topoisomerase II Inhibitors